Low expression of aldehyde deyhdrogenase 1 (ALDH1) is a prognostic marker for poor survival in pancreatic cancer Running title: ALDH-1 is a prognostic marker in pancreatic cancer

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• ALDH1 expression correlates with favorable prognosis in ovarian cancers

  2010cited by this paper
• Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse

  2009cited by this paper
• Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers

  2009cited by this paper
• Identification of pancreatic cancer invasion-related proteins by proteomic analysis

  2009cited by this paper
• Stem cell marker aldehyde dehydrogenase 1‐positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression

  2009influential reference
• Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.

  2009cited by this paper
• Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer.

  2009cited by this paper
• Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer

  2009influential reference
• CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer

  2008cited by this paper
• The Impact of Lymph Node Number on Survival in Patients With Lymph Node-Negative Pancreatic Cancer

  2008cited by this paper
• ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.

  2007cited by this paper
• Prognostic Indicators for Survival after Resection of Pancreatic Adenocarcinoma

  2007cited by this paper
• Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer.

  2007cited by this paper
• One Thousand Consecutive Pancreaticoduodenectomies

  2006cited by this paper
• EXPRESSION OF UBIQUITIN-SPECIFIC PROTEASE 14 IN HUMAN PANCREATIC CANCER CELL LINES AND CANCER TISSUES

  2005cited by this paper
• Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas.

  2003cited by this paper
• A new mathematical model for relative quantification in real-time RT-PCR.

  2001cited by this paper
• Human aldehyde dehydrogenase gene family.

  1998cited by this paper
• Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma.

  1998cited by this paper
• Expression of CD44 Variants and Its Association with Survival in Pancreatic Cancer

  1998cited by this paper
• Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection.

  1996cited by this paper
• Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia.

  1984cited by this paper

• Increased COMT expression in pancreatic cancer and correlation with clinicopathologic parameters

  2012cites this paper
• OMICS Integration Studies for New Insights on Atopic Dermatitis

  year unknowncites this paper